Bayer to sell €3bn hybrid for Merck deal tomorrow, uses dated structure
Bayer, the German chemicals and pharmaceuticals firm, will issue about €3bn of hybrid capital as early as tomorrow, as part of the financing for its takeover of Merck & Co’s consumer care business.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: